Skip to main navigation Skip to search Skip to main content

Resistance in Campylobacter species: Increased resistance to fluoroquinolones and seasonal variation

  • E. Talsma*
  • , W. G. Goettsch
  • , H. L.J. Nieste
  • , P. M. Schrijnemakers
  • , M. J.W. Sprenger
  • *Corresponding author for this work
  • National Institute of Public Health and the Environment
  • Rijnstate Hospital

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

To identify epidemiological features of culture-proven campylobacter infections and to determine resistance rates, we conducted a 4-year demographic survey of culture-proven campylobacteriosis in one Dutch region. Examination of 24,435 fecal specimens revealed 1,315 cases of campylobacteriosis (5.4%). The ofloxacin-resistance rate among Campylobacter isolates increased from 11% to 29%. Resistance against tetracycline fluctuated between 7% and 15%, and resistance against erythromycin remained low. Resistance against fluoroquinolones was seasonally influenced, with relatively high rates during winter. We conclude that resistance of Campylobacter isolates to fluoroquinolones is still rising, probably because of the use of fluoroquinolones (enrofloxacin) in animal husbandry.

Original languageEnglish
Pages (from-to)845-848
Number of pages4
JournalClinical Infectious Diseases
Volume29
Issue number4
DOIs
Publication statusPublished - 1999
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Resistance in Campylobacter species: Increased resistance to fluoroquinolones and seasonal variation'. Together they form a unique fingerprint.

Cite this